Annette Henneberry

Title: Innovations in Antimicrobial Research by Annette Henneberry

Introduction

Annette Henneberry is a notable inventor based in Halifax, Canada. She has made significant contributions to the field of antimicrobial research, particularly through her innovative work on LpxA inhibitors. Her research focuses on developing novel compounds that exhibit antibacterial activity, which is crucial in combating resistant bacterial strains.

Latest Patents

Annette holds 1 patent for her work titled "Synthesis of novel antimicrobials." This patent describes the synthesis and activity of novel LpxA inhibitors, which are designed based on a receptor model developed using the crystal structure of LpxA. The compounds are arranged to ensure favorable binding interactions at the active site of the enzyme. The patent outlines a specific formula where V, W, X, Y, and Z can be independently C, S, N, or O, while P1, P2, and P3 are ligands that bind to the proposed pharmacophore model.

Career Highlights

Throughout her career, Annette has focused on the synthesis of compounds that can effectively target bacterial infections. Her innovative approach to designing LpxA inhibitors showcases her expertise in medicinal chemistry and her commitment to addressing public health challenges.

Collaborations

Annette has collaborated with notable researchers in her field, including Fan Wu and Donald F Weaver. These collaborations have enhanced her research and contributed to the advancement of antimicrobial therapies.

Conclusion

Annette Henneberry's work in synthesizing novel antimicrobials represents a significant advancement in the fight against bacterial infections. Her innovative research continues to pave the way for new therapeutic options in the medical field.